UNCY
Unicycive Therapeutics Inc
4.70$
+0.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | – | – | |
| – | – | – | – | 0.7% | 42.1% | – | – | |
| – | – | – | – | 100.0% | 100.0% | – | – | |
| – | – | – | – | 1,307.7% | 1,911.4% | – | – | |
| – | – | – | – | 690.5% | 1,266.2% | – | – | |
| – | – | – | – | 1,998.2% | 3,177.6% | – | – | |
| – | – | – | – | -1,898.2% | -3,077.6% | – | – | |
| – | – | – | – | 0.6% | 12.1% | – | – | |
| – | – | – | – | -1,898.8% | -4,525.0% | – | – | |
| – | – | – | – | 0.6% | 17.2% | – | – | |
| – | – | – | – | -1,899.5% | -4,525.0% | – | – | |
| – | – | – | – | -1,881.3% | -4,470.8% | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.